Category Archives: Generics

Australian duo find global consumers for Indian generic drugs

By Divya Rajagopal, The Economic Times | May 23, 2017 MUMBAI: Remember Ron the rodeo cowboy from the Oscar-winning film Dallas Buyers Club? The biopic portrayed the story of Ron Woodroof, an AIDS patient in the mid-1980s who signed up … Continue reading

Posted in Generics, Hepatitis C, Sofosbuvir, Uncategorized | Leave a comment

Prescribing Generic Medicines

Source: Economic & Political Weekly April 29, 2017 vol lII no 17 By S. Srinivasan The move to have doctors prescribe medicines in generic names is not a well-planned one. The Prime Minister’s announcement that prescription of medicines by their generic names … Continue reading

Posted in Generics, Uncategorized | Tagged , , | Leave a comment

Pharma Companies Should Sell Medicines Under Generic Names! Generic Prescription by Doctors is NOT Enough

Press Release: April 26, 2017 All India Drug Action Network Demands Substantive Measures   The proposal, as announced by the Prime Minister, to make generic prescription writing mandatory for doctors, would be a useless counterproductive step as a standalone measure. This … Continue reading

Posted in Drug prices, Generics, Uncategorized | Leave a comment

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Pharma PSUs Are Not Ready To Die!

By Murali Neelakantan, BloombergQuintOpinion | February 7, 2017 The government’s decision to explore the strategic sale of Indian Drugs and Pharmaceuticals Ltd. and Bengal Chemicals – even as questions were asked of the move last week by parliamentarians including those from the BJP … Continue reading

Posted in Generics, Patent, Pricing, Uncategorized | Leave a comment

Indian pharma industry fears tougher US stance on IP

Prices of patented drugs are lower in Canada, United Kingdom and Australia in comparison to the US By Aneesh Phadnis & Reuters| Published: Business Standard | february 1, 2017 Indian pharma industry is fearing a tougher US government stance on intellectual … Continue reading

Posted in Generics, IPR, Uncategorized, US pressure on India | Leave a comment

Poor countries allowed to import generic drugs – WTO

By Tom Miles, Reuters | January 23, 2017 Poor countries are allowed to import generic medicines, World Trade Organization (WTO) Director General Roberto Azevedo told Reuters on Monday, after the required two-thirds of members agreed a deal that has taken … Continue reading

Posted in Generics, TRIPS, Uncategorized, WTO | Leave a comment